C3i Meets the Next Generation of Scientists at INRS

An inspiring presentation on the role of CDMOs in Québec’s biotechnology ecosystem

On Monday, April 28, C3i had the pleasure of presenting its mission and expertise at INRS – Institut national de la recherche scientifique, specifically at the Armand-Frappier Santé Biotechnologie Research Centre, located in Laval. This cutting-edge center is renowned for contributing to biomedical sciences, biotechnology, and public health in Québec. During the presentation, our objectives were twofold: to introduce the role of a CDMO (Contract Development and Manufacturing Organization) in the development of innovative therapies, and to highlight C3i’s real-life impact in scaling up, manufacturing, and commercializing therapeutic solutions in the life sciences sector. We had the honor of speaking directly to the next generation of leaders in the biotech industry, sharing our vision, challenges, and the exciting growth opportunities stemming from our presence at the Laval Biotech Park.

A heartfelt thank you to the INRS team for their warm welcome and engaging discussions. Events like this help build lasting bridges between research, industry, and the future of life sciences in Québec.